1
|
Wu JN, Wang T, Chen Y, Tang LJ, Wu HL, Yu RQ. t-SMILES: a fragment-based molecular representation framework for de novo ligand design. Nat Commun 2024; 15:4993. [PMID: 38862578 PMCID: PMC11167009 DOI: 10.1038/s41467-024-49388-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2022] [Accepted: 06/04/2024] [Indexed: 06/13/2024] Open
Abstract
Effective representation of molecules is a crucial factor affecting the performance of artificial intelligence models. This study introduces a flexible, fragment-based, multiscale molecular representation framework called t-SMILES (tree-based SMILES) with three code algorithms: TSSA (t-SMILES with shared atom), TSDY (t-SMILES with dummy atom but without ID) and TSID (t-SMILES with ID and dummy atom). It describes molecules using SMILES-type strings obtained by performing a breadth-first search on a full binary tree formed from a fragmented molecular graph. Systematic evaluations using JTVAE, BRICS, MMPA, and Scaffold show the feasibility of constructing a multi-code molecular description system, where various descriptions complement each other, enhancing the overall performance. In addition, it can avoid overfitting and achieve higher novelty scores while maintaining reasonable similarity on labeled low-resource datasets, regardless of whether the model is original, data-augmented, or pre-trained then fine-tuned. Furthermore, it significantly outperforms classical SMILES, DeepSMILES, SELFIES and baseline models in goal-directed tasks. And it surpasses state-of-the-art fragment, graph and SMILES based approaches on ChEMBL, Zinc, and QM9.
Collapse
Affiliation(s)
- Juan-Ni Wu
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR China
| | - Tong Wang
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR China
| | - Yue Chen
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR China
| | - Li-Juan Tang
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR China
| | - Hai-Long Wu
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR China.
| | - Ru-Qin Yu
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR China.
| |
Collapse
|
2
|
van Tilborg D, Brinkmann H, Criscuolo E, Rossen L, Özçelik R, Grisoni F. Deep learning for low-data drug discovery: Hurdles and opportunities. Curr Opin Struct Biol 2024; 86:102818. [PMID: 38669740 DOI: 10.1016/j.sbi.2024.102818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2024] [Revised: 03/27/2024] [Accepted: 03/29/2024] [Indexed: 04/28/2024]
Abstract
Deep learning is becoming increasingly relevant in drug discovery, from de novo design to protein structure prediction and synthesis planning. However, it is often challenged by the small data regimes typical of certain drug discovery tasks. In such scenarios, deep learning approaches-which are notoriously 'data-hungry'-might fail to live up to their promise. Developing novel approaches to leverage the power of deep learning in low-data scenarios is sparking great attention, and future developments are expected to propel the field further. This mini-review provides an overview of recent low-data-learning approaches in drug discovery, analyzing their hurdles and advantages. Finally, we venture to provide a forecast of future research directions in low-data learning for drug discovery.
Collapse
Affiliation(s)
- Derek van Tilborg
- Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, 5600 MB Eindhoven, the Netherlands; Centre for Living Technologies, Alliance TU/e, WUR, UU, UMC Utrecht, Princetonlaan 6, 3584 CB, Utrecht, the Netherlands. https://twitter.com/DerekvTilborg
| | - Helena Brinkmann
- Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, 5600 MB Eindhoven, the Netherlands. https://twitter.com/hlnbrkmnn
| | - Emanuele Criscuolo
- Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, 5600 MB Eindhoven, the Netherlands. https://twitter.com/emanuelecriscu9
| | - Luke Rossen
- Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, 5600 MB Eindhoven, the Netherlands. https://twitter.com/molecular_ml
| | - Rıza Özçelik
- Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, 5600 MB Eindhoven, the Netherlands; Centre for Living Technologies, Alliance TU/e, WUR, UU, UMC Utrecht, Princetonlaan 6, 3584 CB, Utrecht, the Netherlands. https://twitter.com/Rza_ozcelik
| | - Francesca Grisoni
- Institute for Complex Molecular Systems (ICMS), Department of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, 5600 MB Eindhoven, the Netherlands; Centre for Living Technologies, Alliance TU/e, WUR, UU, UMC Utrecht, Princetonlaan 6, 3584 CB, Utrecht, the Netherlands.
| |
Collapse
|
3
|
Das M, Ghosh A, Sunoj RB. Advances in machine learning with chemical language models in molecular property and reaction outcome predictions. J Comput Chem 2024; 45:1160-1176. [PMID: 38299229 DOI: 10.1002/jcc.27315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Revised: 01/06/2024] [Accepted: 01/09/2024] [Indexed: 02/02/2024]
Abstract
Molecular properties and reactions form the foundation of chemical space. Over the years, innumerable molecules have been synthesized, a smaller fraction of them found immediate applications, while a larger proportion served as a testimony to creative and empirical nature of the domain of chemical science. With increasing emphasis on sustainable practices, it is desirable that a target set of molecules are synthesized preferably through a fewer empirical attempts instead of a larger library, to realize an active candidate. In this front, predictive endeavors using machine learning (ML) models built on available data acquire high timely significance. Prediction of molecular property and reaction outcome remain one of the burgeoning applications of ML in chemical science. Among several methods of encoding molecular samples for ML models, the ones that employ language like representations are gaining steady popularity. Such representations would additionally help adopt well-developed natural language processing (NLP) models for chemical applications. Given this advantageous background, herein we describe several successful chemical applications of NLP focusing on molecular property and reaction outcome predictions. From relatively simpler recurrent neural networks (RNNs) to complex models like transformers, different network architecture have been leveraged for tasks such as de novo drug design, catalyst generation, forward and retro-synthesis predictions. The chemical language model (CLM) provides promising avenues toward a broad range of applications in a time and cost-effective manner. While we showcase an optimistic outlook of CLMs, attention is also placed on the persisting challenges in reaction domain, which would optimistically be addressed by advanced algorithms tailored to chemical language and with increased availability of high-quality datasets.
Collapse
Affiliation(s)
- Manajit Das
- Department of Chemistry, Indian Institute of Technology Bombay, Mumbai, India
| | - Ankit Ghosh
- Department of Chemistry, Indian Institute of Technology Bombay, Mumbai, India
| | - Raghavan B Sunoj
- Department of Chemistry, Indian Institute of Technology Bombay, Mumbai, India
- Centre for Machine Intelligence and Data Science, Indian Institute of Technology Bombay, Mumbai, India
| |
Collapse
|
4
|
Zhang G, Zhang Y, Li L, Zhou J, Chen H, Ji J, Li Y, Cao Y, Xu Z, Pian C. Exploring Novel Fentanyl Analogues Using a Graph-Based Transformer Model. Interdiscip Sci 2024:10.1007/s12539-024-00623-0. [PMID: 38683279 DOI: 10.1007/s12539-024-00623-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2023] [Revised: 02/23/2024] [Accepted: 02/25/2024] [Indexed: 05/01/2024]
Abstract
The structures of fentanyl and its analogues are easy to be modified and few types have been included in database so far, which allow criminals to avoid the supervision of relevant departments. This paper introduces a molecular graph-based transformer model, which is combined with a data augmentation method based on substructure replacement to generate novel fentanyl analogues. 140,000 molecules were generated, and after a set of screening, 36,799 potential fentanyl analogues were finally obtained. We calculated the molecular properties of 36,799 potential fentanyl analogues. The results showed that the model could learn some properties of original fentanyl molecules. We compared the generated molecules from transformer model and data augmentation method based on substructure replacement with those generated by the other two molecular generation models based on deep learning, and found that the model in this paper can generate more novel potential fentanyl analogues. Finally, the findings of the paper indicate that transformer model based on molecular graph helps us explore the structure of potential fentanyl molecules as well as understand distribution of original molecules of fentanyl.
Collapse
Affiliation(s)
- Guangle Zhang
- College of Science, Wuxi University, 214105, Wuxi, China
| | - Yuan Zhang
- College of Agriculture, Nanjing Agricultural University, 210095, Nanjing, China
| | - Ling Li
- Zhejiang Laboratory, 311121, Hangzhou, China
| | - Jiaying Zhou
- College of Science, Nanjing Agricultural University, 210095, Nanjing, China
| | - Honglin Chen
- College of Science, Nanjing Agricultural University, 210095, Nanjing, China
| | - Jinwen Ji
- College of Agriculture, Nanjing Agricultural University, 210095, Nanjing, China
| | - Yanru Li
- College of Agriculture, Nanjing Agricultural University, 210095, Nanjing, China
| | - Yue Cao
- Department of Forensic Medicine, Nanjing Medical University, 211166, Nanjing, China.
| | - Zhihui Xu
- School of Pharmacy, China Pharmaceutical University, 211198, Nanjing, China.
| | - Cong Pian
- School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 211198, Nanjing, China.
| |
Collapse
|
5
|
Atz K, Cotos L, Isert C, Håkansson M, Focht D, Hilleke M, Nippa DF, Iff M, Ledergerber J, Schiebroek CCG, Romeo V, Hiss JA, Merk D, Schneider P, Kuhn B, Grether U, Schneider G. Prospective de novo drug design with deep interactome learning. Nat Commun 2024; 15:3408. [PMID: 38649351 PMCID: PMC11035696 DOI: 10.1038/s41467-024-47613-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Accepted: 04/02/2024] [Indexed: 04/25/2024] Open
Abstract
De novo drug design aims to generate molecules from scratch that possess specific chemical and pharmacological properties. We present a computational approach utilizing interactome-based deep learning for ligand- and structure-based generation of drug-like molecules. This method capitalizes on the unique strengths of both graph neural networks and chemical language models, offering an alternative to the need for application-specific reinforcement, transfer, or few-shot learning. It enables the "zero-shot" construction of compound libraries tailored to possess specific bioactivity, synthesizability, and structural novelty. In order to proactively evaluate the deep interactome learning framework for protein structure-based drug design, potential new ligands targeting the binding site of the human peroxisome proliferator-activated receptor (PPAR) subtype gamma are generated. The top-ranking designs are chemically synthesized and computationally, biophysically, and biochemically characterized. Potent PPAR partial agonists are identified, demonstrating favorable activity and the desired selectivity profiles for both nuclear receptors and off-target interactions. Crystal structure determination of the ligand-receptor complex confirms the anticipated binding mode. This successful outcome positively advocates interactome-based de novo design for application in bioorganic and medicinal chemistry, enabling the creation of innovative bioactive molecules.
Collapse
Affiliation(s)
- Kenneth Atz
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Leandro Cotos
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Clemens Isert
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Maria Håkansson
- SARomics Biostructures AB, Medicon Village, SE-223 81, Lund, Sweden
| | - Dorota Focht
- SARomics Biostructures AB, Medicon Village, SE-223 81, Lund, Sweden
| | - Mattis Hilleke
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - David F Nippa
- Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland
- Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstrasse 5, 81377, Munich, Germany
| | - Michael Iff
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Jann Ledergerber
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Carl C G Schiebroek
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Valentina Romeo
- Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland
| | - Jan A Hiss
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Daniel Merk
- Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstrasse 5, 81377, Munich, Germany
| | - Petra Schneider
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Bernd Kuhn
- Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland
| | - Uwe Grether
- Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070, Basel, Switzerland
| | - Gisbert Schneider
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland.
| |
Collapse
|
6
|
Yao S, Song J, Jia L, Cheng L, Zhong Z, Song M, Feng Z. Fast and effective molecular property prediction with transferability map. Commun Chem 2024; 7:85. [PMID: 38632308 PMCID: PMC11024153 DOI: 10.1038/s42004-024-01169-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2023] [Accepted: 04/05/2024] [Indexed: 04/19/2024] Open
Abstract
Effective transfer learning for molecular property prediction has shown considerable strength in addressing insufficient labeled molecules. Many existing methods either disregard the quantitative relationship between source and target properties, risking negative transfer, or require intensive training on target tasks. To quantify transferability concerning task-relatedness, we propose Principal Gradient-based Measurement (PGM) for transferring molecular property prediction ability. First, we design an optimization-free scheme to calculate a principal gradient for approximating the direction of model optimization on a molecular property prediction dataset. We have analyzed the close connection between the principal gradient and model optimization through mathematical proof. PGM measures the transferability as the distance between the principal gradient obtained from the source dataset and that derived from the target dataset. Then, we perform PGM on various molecular property prediction datasets to build a quantitative transferability map for source dataset selection. Finally, we evaluate PGM on multiple combinations of transfer learning tasks across 12 benchmark molecular property prediction datasets and demonstrate that it can serve as fast and effective guidance to improve the performance of a target task. This work contributes to more efficient discovery of drugs, materials, and catalysts by offering a task-relatedness quantification prior to transfer learning and understanding the relationship between chemical properties.
Collapse
Affiliation(s)
- Shaolun Yao
- Collaborative Innovation Center of Artificial Intelligence by MOE and Zhejiang Provincial Government, Zhejiang University, 310027, Hangzhou, China
- College of Computer Science and Technology, Zhejiang University, 310027, Hangzhou, China
- Shanghai Institute for Advanced Study of Zhejiang University, 201203, Shanghai, China
| | - Jie Song
- Shanghai Institute for Advanced Study of Zhejiang University, 201203, Shanghai, China
- School of Software Technology, Zhejiang University, 315048, Ningbo, China
| | - Lingxiang Jia
- College of Computer Science and Technology, Zhejiang University, 310027, Hangzhou, China
| | - Lechao Cheng
- School of Computer Science and Information Engineering, Hefei University of Technology, 230009, Hefei, China
| | - Zipeng Zhong
- College of Computer Science and Technology, Zhejiang University, 310027, Hangzhou, China
| | - Mingli Song
- College of Computer Science and Technology, Zhejiang University, 310027, Hangzhou, China
- Shanghai Institute for Advanced Study of Zhejiang University, 201203, Shanghai, China
| | - Zunlei Feng
- Shanghai Institute for Advanced Study of Zhejiang University, 201203, Shanghai, China.
- School of Software Technology, Zhejiang University, 315048, Ningbo, China.
| |
Collapse
|
7
|
Xu T, Gao W, Zhu L, Chen W, Niu C, Yin W, Ma L, Zhu X, Ling Y, Gao S, Liu L, Jiao N, Chen W, Zhang G, Zhu R, Wu D. NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease. J Chem Inf Model 2024; 64:2817-2828. [PMID: 37167092 DOI: 10.1021/acs.jcim.3c00395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with a broad spectrum of histologic manifestations. The rapidly growing prevalence and the complex pathologic mechanisms of NAFLD pose great challenges for treatment development. Despite tremendous efforts devoted to drug development, there are no FDA-approved medicines yet. Here, we present NAFLDkb, a specialized knowledge base and platform for computer-aided drug design against NAFLD. With multiperspective information curated from diverse source materials and public databases, NAFLDkb presents the associations of drug-related entities as individual knowledge graphs. Practical drug discovery tools that facilitate the utilization and expansion of NAFLDkb have also been implemented in the web interface, including chemical structure search, drug-likeness screening, knowledge-based repositioning, and research article annotation. Moreover, case studies of a knowledge graph repositioning model and a generative neural network model are presented herein, where three repositioning drug candidates and 137 novel lead-like compounds were newly established as NAFLD pharmacotherapy options reusing data records and machine learning tools in NAFLDkb, suggesting its clinical reliability and great potential in identifying novel drug-disease associations of NAFLD and generating new insights to accelerate NAFLD drug development. NAFLDkb is freely accessible at https://www.biosino.org/nafldkb and will be updated periodically with the latest findings.
Collapse
Affiliation(s)
- Tingjun Xu
- Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200060, P. R. China
- Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 LingLing Road, Shanghai 200032, P. R. China
| | - Wenxing Gao
- Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200060, P. R. China
| | - Lixin Zhu
- Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases; Biomedical Innovation Center, Sun Yat-sen University, Guangzhou 510655, P. R. China
- Department of General Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, P. R. China
| | - Wanning Chen
- Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200060, P. R. China
| | - Chaoqun Niu
- Chinese Academy of Sciences Key Laboratory of Computational Biology, Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, University of the Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, P. R. China
| | - Wenjing Yin
- Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200060, P. R. China
| | - Liangxiao Ma
- Chinese Academy of Sciences Key Laboratory of Computational Biology, Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, University of the Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, P. R. China
| | - Xinyue Zhu
- Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200060, P. R. China
| | - Yunchao Ling
- Chinese Academy of Sciences Key Laboratory of Computational Biology, Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, University of the Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, P. R. China
| | - Sheng Gao
- Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200060, P. R. China
| | - Lei Liu
- Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200060, P. R. China
| | - Na Jiao
- National Clinical Research Center for Child Health, the Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, P. R. China
| | - Weiming Chen
- Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 LingLing Road, Shanghai 200032, P. R. China
| | - Guoqing Zhang
- Chinese Academy of Sciences Key Laboratory of Computational Biology, Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, University of the Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, P. R. China
| | - Ruixin Zhu
- Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200060, P. R. China
| | - Dingfeng Wu
- National Clinical Research Center for Child Health, the Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, P. R. China
| |
Collapse
|
8
|
Vogt M. Chemoinformatic approaches for navigating large chemical spaces. Expert Opin Drug Discov 2024; 19:403-414. [PMID: 38300511 DOI: 10.1080/17460441.2024.2313475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Accepted: 01/30/2024] [Indexed: 02/02/2024]
Abstract
INTRODUCTION Large chemical spaces (CSs) include traditional large compound collections, combinatorial libraries covering billions to trillions of molecules, DNA-encoded chemical libraries comprising complete combinatorial CSs in a single mixture, and virtual CSs explored by generative models. The diverse nature of these types of CSs require different chemoinformatic approaches for navigation. AREAS COVERED An overview of different types of large CSs is provided. Molecular representations and similarity metrics suitable for large CS exploration are discussed. A summary of navigation of CSs in generative models is provided. Methods for characterizing and comparing CSs are discussed. EXPERT OPINION The size of large CSs might restrict navigation to specialized algorithms and limit it to considering neighborhoods of structurally similar molecules. Efficient navigation of large CSs not only requires methods that scale with size but also requires smart approaches that focus on better but not necessarily larger molecule selections. Deep generative models aim to provide such approaches by implicitly learning features relevant for targeted biological properties. It is unclear whether these models can fulfill this ideal as validation is difficult as long as the covered CSs remain mainly virtual without experimental verification.
Collapse
Affiliation(s)
- Martin Vogt
- Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| |
Collapse
|
9
|
Loeffler HH, He J, Tibo A, Janet JP, Voronov A, Mervin LH, Engkvist O. Reinvent 4: Modern AI-driven generative molecule design. J Cheminform 2024; 16:20. [PMID: 38383444 PMCID: PMC10882833 DOI: 10.1186/s13321-024-00812-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Accepted: 02/09/2024] [Indexed: 02/23/2024] Open
Abstract
REINVENT 4 is a modern open-source generative AI framework for the design of small molecules. The software utilizes recurrent neural networks and transformer architectures to drive molecule generation. These generators are seamlessly embedded within the general machine learning optimization algorithms, transfer learning, reinforcement learning and curriculum learning. REINVENT 4 enables and facilitates de novo design, R-group replacement, library design, linker design, scaffold hopping and molecule optimization. This contribution gives an overview of the software and describes its design. Algorithms and their applications are discussed in detail. REINVENT 4 is a command line tool which reads a user configuration in either TOML or JSON format. The aim of this release is to provide reference implementations for some of the most common algorithms in AI based molecule generation. An additional goal with the release is to create a framework for education and future innovation in AI based molecular design. The software is available from https://github.com/MolecularAI/REINVENT4 and released under the permissive Apache 2.0 license. Scientific contribution. The software provides an open-source reference implementation for generative molecular design where the software is also being used in production to support in-house drug discovery projects. The publication of the most common machine learning algorithms in one code and full documentation thereof will increase transparency of AI and foster innovation, collaboration and education.
Collapse
Affiliation(s)
- Hannes H Loeffler
- Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
| | - Jiazhen He
- Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden
| | - Alessandro Tibo
- Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden
| | - Jon Paul Janet
- Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden
| | - Alexey Voronov
- Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden
| | - Lewis H Mervin
- Molecular AI, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK
| | - Ola Engkvist
- Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden
| |
Collapse
|
10
|
Gangwal A, Ansari A, Ahmad I, Azad AK, Kumarasamy V, Subramaniyan V, Wong LS. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities. Front Pharmacol 2024; 15:1331062. [PMID: 38384298 PMCID: PMC10879372 DOI: 10.3389/fphar.2024.1331062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Accepted: 01/17/2024] [Indexed: 02/23/2024] Open
Abstract
There are two main ways to discover or design small drug molecules. The first involves fine-tuning existing molecules or commercially successful drugs through quantitative structure-activity relationships and virtual screening. The second approach involves generating new molecules through de novo drug design or inverse quantitative structure-activity relationship. Both methods aim to get a drug molecule with the best pharmacokinetic and pharmacodynamic profiles. However, bringing a new drug to market is an expensive and time-consuming endeavor, with the average cost being estimated at around $2.5 billion. One of the biggest challenges is screening the vast number of potential drug candidates to find one that is both safe and effective. The development of artificial intelligence in recent years has been phenomenal, ushering in a revolution in many fields. The field of pharmaceutical sciences has also significantly benefited from multiple applications of artificial intelligence, especially drug discovery projects. Artificial intelligence models are finding use in molecular property prediction, molecule generation, virtual screening, synthesis planning, repurposing, among others. Lately, generative artificial intelligence has gained popularity across domains for its ability to generate entirely new data, such as images, sentences, audios, videos, novel chemical molecules, etc. Generative artificial intelligence has also delivered promising results in drug discovery and development. This review article delves into the fundamentals and framework of various generative artificial intelligence models in the context of drug discovery via de novo drug design approach. Various basic and advanced models have been discussed, along with their recent applications. The review also explores recent examples and advances in the generative artificial intelligence approach, as well as the challenges and ongoing efforts to fully harness the potential of generative artificial intelligence in generating novel drug molecules in a faster and more affordable manner. Some clinical-level assets generated form generative artificial intelligence have also been discussed in this review to show the ever-increasing application of artificial intelligence in drug discovery through commercial partnerships.
Collapse
Affiliation(s)
- Amit Gangwal
- Department of Natural Product Chemistry, Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, Maharashtra, India
| | - Azim Ansari
- Computer Aided Drug Design Center Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, Maharashtra, India
| | - Iqrar Ahmad
- Department of Pharmaceutical Chemistry, Prof. Ravindra Nikam College of Pharmacy, Dhule, India
| | - Abul Kalam Azad
- Faculty of Pharmacy, University College of MAIWP International, Batu Caves, Malaysia
| | - Vinoth Kumarasamy
- Department of Parasitology and Medical Entomology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Malaysia
| | - Vetriselvan Subramaniyan
- Pharmacology Unit, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia
- School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, Punjab, India
| | - Ling Shing Wong
- Faculty of Health and Life Sciences, INTI International University, Nilai, Malaysia
| |
Collapse
|
11
|
Bajorath J. Chemical language models for molecular design. Mol Inform 2024; 43:e202300288. [PMID: 38010610 DOI: 10.1002/minf.202300288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2023] [Revised: 11/22/2023] [Accepted: 11/23/2023] [Indexed: 11/29/2023]
Abstract
In drug discovery, chemical language models (CLMs) originating from natural language processing offer new opportunities for molecular design. CLMs have been developed using recurrent neural network (RNN) or transformer architectures. For the predictive performance of RNN-based encoder-decoder frameworks and transformers, attention mechanisms play a central role. Among others, emerging application areas for CLMs include constrained generative modeling and the prediction of chemical reactions or drug-target interactions. Since CLMs are applicable to any compound or target data that can be presented in a sequential format and tokenized, mappings of different types of sequences can be learned. For example, active compounds can be predicted from protein sequence motifs. Novel off-the-beat-path applications can also be considered. For example, analogue series from medicinal chemistry can be perceived and represented as chemical sequences and extended with new compounds using CLMs. Herein, methodological features of CLMs and different applications are discussed.
Collapse
Affiliation(s)
- Jürgen Bajorath
- Department of Life Science Informatics, Bonn-Aachen International Center for Information Technology, Rheinische Friedrich-Wilhelms-Universität Bonn, Friedrich-Hirzebruch-Allee 5/6, D-53115, Bonn, Germany
- Lamarr Institute for Machine Learning and Artificial Intelligence, Rheinische Friedrich-Wilhelms-Universität Bonn, Friedrich-Hirzebruch-Allee 5/6, D-53115, Bonn, Germany
| |
Collapse
|
12
|
Wang F, Pasin D, Skinnider MA, Liigand J, Kleis JN, Brown D, Oler E, Sajed T, Gautam V, Harrison S, Greiner R, Foster LJ, Dalsgaard PW, Wishart DS. Deep Learning-Enabled MS/MS Spectrum Prediction Facilitates Automated Identification Of Novel Psychoactive Substances. Anal Chem 2023; 95:18326-18334. [PMID: 38048435 PMCID: PMC10733899 DOI: 10.1021/acs.analchem.3c02413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2023] [Revised: 11/10/2023] [Accepted: 11/13/2023] [Indexed: 12/06/2023]
Abstract
The market for illicit drugs has been reshaped by the emergence of more than 1100 new psychoactive substances (NPS) over the past decade, posing a major challenge to the forensic and toxicological laboratories tasked with detecting and identifying them. Tandem mass spectrometry (MS/MS) is the primary method used to screen for NPS within seized materials or biological samples. The most contemporary workflows necessitate labor-intensive and expensive MS/MS reference standards, which may not be available for recently emerged NPS on the illicit market. Here, we present NPS-MS, a deep learning method capable of accurately predicting the MS/MS spectra of known and hypothesized NPS from their chemical structures alone. NPS-MS is trained by transfer learning from a generic MS/MS prediction model on a large data set of MS/MS spectra. We show that this approach enables a more accurate identification of NPS from experimentally acquired MS/MS spectra than any existing method. We demonstrate the application of NPS-MS to identify a novel derivative of phencyclidine (PCP) within an unknown powder seized in Denmark without the use of any reference standards. We anticipate that NPS-MS will allow forensic laboratories to identify more rapidly both known and newly emerging NPS. NPS-MS is available as a web server at https://nps-ms.ca/, which provides MS/MS spectra prediction capabilities for given NPS compounds. Additionally, it offers MS/MS spectra identification against a vast database comprising approximately 8.7 million predicted NPS compounds from DarkNPS and 24.5 million predicted ESI-QToF-MS/MS spectra for these compounds.
Collapse
Affiliation(s)
- Fei Wang
- Department
of Computing Science, University of Alberta, Edmonton, Alberta T6G 2E8, Canada
- Alberta
Machine Intelligence Institute, Edmonton, Alberta T5J
3B1, Canada
| | - Daniel Pasin
- Section
of Forensic Chemistry, Department of Forensic Medicine, University of Copenhagen, Copenhagen 2100, Denmark
| | - Michael A. Skinnider
- Michael
Smith Laboratories, University of British
Columbia, Vancouver, British Columbia V6T 1Z4, Canada
- Lewis-Sigler
Institute for Integrative Genomics, Princeton
University, Princeton, New Jersey 08544, United States
- Ludwig Institute
for Cancer Research, Princeton University, Princeton, New Jersey 08544, United States
| | - Jaanus Liigand
- Department
of Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada
- Institute
of Chemistry, University of Tartu, Tartu 50411, Estonia
| | - Jan-Niklas Kleis
- Institute
of Forensic Medicine, Forensic Toxicology, Johannes Gutenberg University Mainz, Mainz 55131, Germany
| | - David Brown
- Forensic
Science Laboratory, ChemCentre, Bentley, Western Australia 6102, Australia
- School of Molecular and Life Sciences, Curtin University, Bentley, Western Australia 6009, Australia
| | - Eponine Oler
- Department
of Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada
| | - Tanvir Sajed
- Department
of Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada
| | - Vasuk Gautam
- Department
of Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada
| | - Stephen Harrison
- Forensic
Science Laboratory, ChemCentre, Bentley, Western Australia 6102, Australia
| | - Russell Greiner
- Department
of Computing Science, University of Alberta, Edmonton, Alberta T6G 2E8, Canada
- Alberta
Machine Intelligence Institute, Edmonton, Alberta T5J
3B1, Canada
| | - Leonard J. Foster
- Michael
Smith Laboratories, University of British
Columbia, Vancouver, British Columbia V6T 1Z4, Canada
- Department
of Biochemistry and Molecular Biology, University
of British Columbia, Vancouver, British Columbia V6T 2A1, Canada
| | - Petur Weihe Dalsgaard
- Section
of Forensic Chemistry, Department of Forensic Medicine, University of Copenhagen, Copenhagen 2100, Denmark
| | - David S. Wishart
- Department
of Computing Science, University of Alberta, Edmonton, Alberta T6G 2E8, Canada
- Department
of Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada
- Department of Laboratory
Medicine and Pathology, University of Alberta, Edmonton, Alberta T6G 1C9, Canada
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2C8, Canada
- Biological Sciences Division, Pacific Northwest
National Laboratory, Richland, Washington 99354, United States
| |
Collapse
|
13
|
Skinnider MA, Mérette SAM, Pasin D, Rogalski J, Foster LJ, Scheuermeyer F, Shapiro AM. Identification of Emerging Novel Psychoactive Substances by Retrospective Analysis of Population-Scale Mass Spectrometry Data Sets. Anal Chem 2023; 95:17300-17310. [PMID: 37966487 DOI: 10.1021/acs.analchem.3c03451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2023]
Abstract
Over the last two decades, hundreds of new psychoactive substances (NPSs), also known as "designer drugs", have emerged on the illicit drug market. The toxic and potentially fatal effects of these compounds oblige laboratories around the world to screen for NPS in seized materials and biological samples, commonly using high-resolution mass spectrometry. However, unambiguous identification of a NPS by mass spectrometry requires comparison to data from analytical reference materials, acquired on the same instrument. The sheer number of NPSs that are available on the illicit market, and the pace at which new compounds are introduced, means that forensic laboratories must make difficult decisions about which reference materials to acquire. Here, we asked whether retrospective suspect screening of population-scale mass spectrometry data could provide a data-driven platform to prioritize emerging NPSs for assay development. We curated a suspect database of precursor and diagnostic fragment ion masses for 83 emerging NPSs and used this database to retrospectively screen mass spectrometry data from 12,727 urine drug screens from one Canadian province. We developed integrative computational strategies to prioritize the most reliable identifications and tracked the frequency of these identifications over a 3 year study period between August 2019 and August 2022. The resulting data were used to guide the acquisition of new reference materials, which were in turn used to validate a subset of the retrospective identifications. Last, we took advantage of matching clinical reports for all 12,727 samples to systematically benchmark the accuracy of our retrospective data analysis approach. Our work opens up new avenues to enable the rapid detection of emerging illicit drugs through large-scale reanalysis of mass spectrometry data.
Collapse
Affiliation(s)
- Michael A Skinnider
- Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
- Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, New Jersey 08544, United States
- Ludwig Institute for Cancer Research, Princeton University, Princeton, New Jersey 08544, United States
| | - Sandrine A M Mérette
- Provincial Toxicology Centre, Provincial Health Services Authority, Vancouver, British Columbia V5Z 4R4, Canada
| | - Daniel Pasin
- Forensic Laboratory Division, Office of the Chief Medical Examiner, San Francisco, California 94124, United States
| | - Jason Rogalski
- Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
| | - Leonard J Foster
- Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
- Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
| | - Frank Scheuermeyer
- Department of Emergency Medicine, St. Paul's Hospital and the University of British Columbia, Vancouver, British Columbia V6Z IY6, Canada
- Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia V6Z IY6, Canada
| | - Aaron M Shapiro
- Provincial Toxicology Centre, Provincial Health Services Authority, Vancouver, British Columbia V5Z 4R4, Canada
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada
| |
Collapse
|
14
|
Ochiai T, Inukai T, Akiyama M, Furui K, Ohue M, Matsumori N, Inuki S, Uesugi M, Sunazuka T, Kikuchi K, Kakeya H, Sakakibara Y. Variational autoencoder-based chemical latent space for large molecular structures with 3D complexity. Commun Chem 2023; 6:249. [PMID: 37973971 PMCID: PMC10654724 DOI: 10.1038/s42004-023-01054-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2023] [Accepted: 11/06/2023] [Indexed: 11/19/2023] Open
Abstract
The structural diversity of chemical libraries, which are systematic collections of compounds that have potential to bind to biomolecules, can be represented by chemical latent space. A chemical latent space is a projection of a compound structure into a mathematical space based on several molecular features, and it can express structural diversity within a compound library in order to explore a broader chemical space and generate novel compound structures for drug candidates. In this study, we developed a deep-learning method, called NP-VAE (Natural Product-oriented Variational Autoencoder), based on variational autoencoder for managing hard-to-analyze datasets from DrugBank and large molecular structures such as natural compounds with chirality, an essential factor in the 3D complexity of compounds. NP-VAE was successful in constructing the chemical latent space from large-sized compounds that were unable to be handled in existing methods, achieving higher reconstruction accuracy, and demonstrating stable performance as a generative model across various indices. Furthermore, by exploring the acquired latent space, we succeeded in comprehensively analyzing a compound library containing natural compounds and generating novel compound structures with optimized functions.
Collapse
Grants
- 22H04901 Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 17H06410 Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 23H04885 Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 23H04880 Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 23H04881 Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 23H04887 Ministry of Education, Culture, Sports, Science and Technology (MEXT)
Collapse
Affiliation(s)
- Toshiki Ochiai
- Department of Biosciences and Informatics, Keio University, Yokohama, Kanagawa, 223-8522, Japan
| | - Tensei Inukai
- Department of Biosciences and Informatics, Keio University, Yokohama, Kanagawa, 223-8522, Japan
| | - Manato Akiyama
- Department of Biosciences and Informatics, Keio University, Yokohama, Kanagawa, 223-8522, Japan
| | - Kairi Furui
- Department of Computer Science, School of Computing, Tokyo Institute of Technology, Yokohama, Kanagawa, 226-8501, Japan
| | - Masahito Ohue
- Department of Computer Science, School of Computing, Tokyo Institute of Technology, Yokohama, Kanagawa, 226-8501, Japan
| | - Nobuaki Matsumori
- Department of Chemistry, Graduate School of Science, Kyushu University, Fukuoka, Fukuoka, 819-0395, Japan
| | - Shinsuke Inuki
- Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Kyoto, 606-8501, Japan
| | - Motonari Uesugi
- Institute for Chemical Research and WPI-iCeMS, Kyoto University, Uji, Kyoto, 611-0011, Japan
| | - Toshiaki Sunazuka
- Omura Satoshi Memorial Institute and Graduate School of Infection Control Sciences, Kitasato University, Minato-ku, Tokyo, 108-8641, Japan
| | - Kazuya Kikuchi
- Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Suita, Osaka, 565-0871, Japan
- Immunology Frontier Research Centre, Osaka University, Suita, Osaka, 565-0871, Japan
| | - Hideaki Kakeya
- Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Kyoto, 606-8501, Japan
| | - Yasubumi Sakakibara
- Department of Biosciences and Informatics, Keio University, Yokohama, Kanagawa, 223-8522, Japan.
- Department of Data Science, Kitasato University School of Frontier Engineering, Sagamihara, Kanagawa, 252-0373, Japan.
| |
Collapse
|
15
|
Xia S, Chen E, Zhang Y. Integrated Molecular Modeling and Machine Learning for Drug Design. J Chem Theory Comput 2023; 19:7478-7495. [PMID: 37883810 PMCID: PMC10653122 DOI: 10.1021/acs.jctc.3c00814] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Revised: 10/10/2023] [Accepted: 10/11/2023] [Indexed: 10/28/2023]
Abstract
Modern therapeutic development often involves several stages that are interconnected, and multiple iterations are usually required to bring a new drug to the market. Computational approaches have increasingly become an indispensable part of helping reduce the time and cost of the research and development of new drugs. In this Perspective, we summarize our recent efforts on integrating molecular modeling and machine learning to develop computational tools for modulator design, including a pocket-guided rational design approach based on AlphaSpace to target protein-protein interactions, delta machine learning scoring functions for protein-ligand docking as well as virtual screening, and state-of-the-art deep learning models to predict calculated and experimental molecular properties based on molecular mechanics optimized geometries. Meanwhile, we discuss remaining challenges and promising directions for further development and use a retrospective example of FDA approved kinase inhibitor Erlotinib to demonstrate the use of these newly developed computational tools.
Collapse
Affiliation(s)
- Song Xia
- Department
of Chemistry, New York University, New York, New York 10003, United States
| | - Eric Chen
- Department
of Chemistry, New York University, New York, New York 10003, United States
| | - Yingkai Zhang
- Department
of Chemistry, New York University, New York, New York 10003, United States
- Simons
Center for Computational Physical Chemistry at New York University, New York, New York 10003, United States
- NYU-ECNU
Center for Computational Chemistry at NYU Shanghai, Shanghai 200062, China
| |
Collapse
|
16
|
Kim GB, Kim JY, Lee JA, Norsigian CJ, Palsson BO, Lee SY. Functional annotation of enzyme-encoding genes using deep learning with transformer layers. Nat Commun 2023; 14:7370. [PMID: 37963869 PMCID: PMC10645960 DOI: 10.1038/s41467-023-43216-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Accepted: 11/03/2023] [Indexed: 11/16/2023] Open
Abstract
Functional annotation of open reading frames in microbial genomes remains substantially incomplete. Enzymes constitute the most prevalent functional gene class in microbial genomes and can be described by their specific catalytic functions using the Enzyme Commission (EC) number. Consequently, the ability to predict EC numbers could substantially reduce the number of un-annotated genes. Here we present a deep learning model, DeepECtransformer, which utilizes transformer layers as a neural network architecture to predict EC numbers. Using the extensively studied Escherichia coli K-12 MG1655 genome, DeepECtransformer predicted EC numbers for 464 un-annotated genes. We experimentally validated the enzymatic activities predicted for three proteins (YgfF, YciO, and YjdM). Further examination of the neural network's reasoning process revealed that the trained neural network relies on functional motifs of enzymes to predict EC numbers. Thus, DeepECtransformer is a method that facilitates the functional annotation of uncharacterized genes.
Collapse
Affiliation(s)
- Gi Bae Kim
- Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea
- Systems Metabolic Engineering and Systems Healthcare Cross-Generation Collaborative Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), KAIST, Daejeon, 34141, Republic of Korea
- KAIST Institute for the BioCentury and KAIST Institute for Artificial Intelligence, KAIST, Daejeon, 34141, Republic of Korea
| | - Ji Yeon Kim
- Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea
- Systems Metabolic Engineering and Systems Healthcare Cross-Generation Collaborative Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), KAIST, Daejeon, 34141, Republic of Korea
- KAIST Institute for the BioCentury and KAIST Institute for Artificial Intelligence, KAIST, Daejeon, 34141, Republic of Korea
| | - Jong An Lee
- Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea
- Systems Metabolic Engineering and Systems Healthcare Cross-Generation Collaborative Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), KAIST, Daejeon, 34141, Republic of Korea
- KAIST Institute for the BioCentury and KAIST Institute for Artificial Intelligence, KAIST, Daejeon, 34141, Republic of Korea
| | - Charles J Norsigian
- Division of Biological Sciences, University of California San Diego, La Jolla, CA, 92093, USA
- Department of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA
| | - Bernhard O Palsson
- Department of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA
- Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, 92093, USA
- Novo Nordisk Foundation Center for Biosustainability, 2800, Kongens Lyngby, Denmark
| | - Sang Yup Lee
- Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
- Systems Metabolic Engineering and Systems Healthcare Cross-Generation Collaborative Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), KAIST, Daejeon, 34141, Republic of Korea.
- KAIST Institute for the BioCentury and KAIST Institute for Artificial Intelligence, KAIST, Daejeon, 34141, Republic of Korea.
- BioProcess Engineering Research Center and BioInformatics Research Center, KAIST, Daejeon, 34141, Republic of Korea.
| |
Collapse
|
17
|
Skinnider MA. Hallucinating hallucinogens. Science 2023; 382:656-657. [PMID: 37943903 DOI: 10.1126/science.adk8626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2023]
Abstract
Fighting the designer drug epidemic with generative AI.
Collapse
Affiliation(s)
- Michael A Skinnider
- Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA
- Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA
| |
Collapse
|
18
|
Wang H, Fu T, Du Y, Gao W, Huang K, Liu Z, Chandak P, Liu S, Van Katwyk P, Deac A, Anandkumar A, Bergen K, Gomes CP, Ho S, Kohli P, Lasenby J, Leskovec J, Liu TY, Manrai A, Marks D, Ramsundar B, Song L, Sun J, Tang J, Veličković P, Welling M, Zhang L, Coley CW, Bengio Y, Zitnik M. Scientific discovery in the age of artificial intelligence. Nature 2023; 620:47-60. [PMID: 37532811 DOI: 10.1038/s41586-023-06221-2] [Citation(s) in RCA: 69] [Impact Index Per Article: 69.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Accepted: 05/16/2023] [Indexed: 08/04/2023]
Abstract
Artificial intelligence (AI) is being increasingly integrated into scientific discovery to augment and accelerate research, helping scientists to generate hypotheses, design experiments, collect and interpret large datasets, and gain insights that might not have been possible using traditional scientific methods alone. Here we examine breakthroughs over the past decade that include self-supervised learning, which allows models to be trained on vast amounts of unlabelled data, and geometric deep learning, which leverages knowledge about the structure of scientific data to enhance model accuracy and efficiency. Generative AI methods can create designs, such as small-molecule drugs and proteins, by analysing diverse data modalities, including images and sequences. We discuss how these methods can help scientists throughout the scientific process and the central issues that remain despite such advances. Both developers and users of AI toolsneed a better understanding of when such approaches need improvement, and challenges posed by poor data quality and stewardship remain. These issues cut across scientific disciplines and require developing foundational algorithmic approaches that can contribute to scientific understanding or acquire it autonomously, making them critical areas of focus for AI innovation.
Collapse
Affiliation(s)
- Hanchen Wang
- Department of Engineering, University of Cambridge, Cambridge, UK
- Department of Computing and Mathematical Sciences, California Institute of Technology, Pasadena, CA, USA
- Department of Research and Early Development, Genentech Inc, South San Francisco, CA, USA
- Department of Computer Science, Stanford University, Stanford, CA, USA
| | - Tianfan Fu
- Department of Computational Science and Engineering, Georgia Institute of Technology, Atlanta, GA, USA
| | - Yuanqi Du
- Department of Computer Science, Cornell University, Ithaca, NY, USA
| | - Wenhao Gao
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Kexin Huang
- Department of Computer Science, Stanford University, Stanford, CA, USA
| | - Ziming Liu
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Payal Chandak
- Harvard-MIT Program in Health Sciences and Technology, Cambridge, MA, USA
| | - Shengchao Liu
- Mila - Quebec AI Institute, Montreal, Quebec, Canada
- Université de Montréal, Montreal, Quebec, Canada
| | - Peter Van Katwyk
- Department of Earth, Environmental and Planetary Sciences, Brown University, Providence, RI, USA
- Data Science Institute, Brown University, Providence, RI, USA
| | - Andreea Deac
- Mila - Quebec AI Institute, Montreal, Quebec, Canada
- Université de Montréal, Montreal, Quebec, Canada
| | - Anima Anandkumar
- Department of Computing and Mathematical Sciences, California Institute of Technology, Pasadena, CA, USA
- NVIDIA, Santa Clara, CA, USA
| | - Karianne Bergen
- Department of Earth, Environmental and Planetary Sciences, Brown University, Providence, RI, USA
- Data Science Institute, Brown University, Providence, RI, USA
| | - Carla P Gomes
- Department of Computer Science, Cornell University, Ithaca, NY, USA
| | - Shirley Ho
- Center for Computational Astrophysics, Flatiron Institute, New York, NY, USA
- Department of Astrophysical Sciences, Princeton University, Princeton, NJ, USA
- Department of Physics, Carnegie Mellon University, Pittsburgh, PA, USA
- Department of Physics and Center for Data Science, New York University, New York, NY, USA
| | | | - Joan Lasenby
- Department of Engineering, University of Cambridge, Cambridge, UK
| | - Jure Leskovec
- Department of Computer Science, Stanford University, Stanford, CA, USA
| | | | - Arjun Manrai
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA
| | - Debora Marks
- Department of Systems Biology, Harvard Medical School, Boston, MA, USA
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | | | - Le Song
- BioMap, Beijing, China
- Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, United Arab Emirates
| | - Jimeng Sun
- University of Illinois at Urbana-Champaign, Champaign, IL, USA
| | - Jian Tang
- Mila - Quebec AI Institute, Montreal, Quebec, Canada
- HEC Montréal, Montreal, Quebec, Canada
- CIFAR AI Chair, Toronto, Ontario, Canada
| | - Petar Veličković
- Google DeepMind, London, UK
- Department of Computer Science and Technology, University of Cambridge, Cambridge, UK
| | - Max Welling
- University of Amsterdam, Amsterdam, Netherlands
- Microsoft Research Amsterdam, Amsterdam, Netherlands
| | - Linfeng Zhang
- DP Technology, Beijing, China
- AI for Science Institute, Beijing, China
| | - Connor W Coley
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
- Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Yoshua Bengio
- Mila - Quebec AI Institute, Montreal, Quebec, Canada
- Université de Montréal, Montreal, Quebec, Canada
| | - Marinka Zitnik
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Harvard Data Science Initiative, Cambridge, MA, USA.
- Kempner Institute for the Study of Natural and Artificial Intelligence, Harvard University, Cambridge, MA, USA.
| |
Collapse
|
19
|
Tay DWP, Yeo NZX, Adaikkappan K, Lim YH, Ang SJ. 67 million natural product-like compound database generated via molecular language processing. Sci Data 2023; 10:296. [PMID: 37208372 DOI: 10.1038/s41597-023-02207-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Accepted: 04/21/2023] [Indexed: 05/21/2023] Open
Abstract
Natural products are a rich resource of bioactive compounds for valuable applications across multiple fields such as food, agriculture, and medicine. For natural product discovery, high throughput in silico screening offers a cost-effective alternative to traditional resource-heavy assay-guided exploration of structurally novel chemical space. In this data descriptor, we report a characterized database of 67,064,204 natural product-like molecules generated using a recurrent neural network trained on known natural products, demonstrating a significant 165-fold expansion in library size over the approximately 400,000 known natural products. This study highlights the potential of using deep generative models to explore novel natural product chemical space for high throughput in silico discovery.
Collapse
Affiliation(s)
- Dillon W P Tay
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, #07-01 Neuros Building, Singapore, 138665, Republic of Singapore.
| | - Naythan Z X Yeo
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, #07-01 Neuros Building, Singapore, 138665, Republic of Singapore
- Hwa Chong Institution, 661 Bukit Timah Road, Singapore, 269734, Republic of Singapore
| | - Krishnan Adaikkappan
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, #07-01 Neuros Building, Singapore, 138665, Republic of Singapore
- National Junior College, 37 Hillcrest Road, Singapore, 288913, Republic of Singapore
| | - Yee Hwee Lim
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, #07-01 Neuros Building, Singapore, 138665, Republic of Singapore
- Synthetic Biology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, Singapore, 117597, Republic of Singapore
| | - Shi Jun Ang
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, #07-01 Neuros Building, Singapore, 138665, Republic of Singapore.
- Institute of High Performance Computing (IHPC), Agency for Science, Technology and Research (A*STAR), 1 Fusionopolis Way, #16-16 Connexis, Singapore, 138632, Republic of Singapore.
| |
Collapse
|
20
|
Yoshimori A, Bajorath J. Motif2Mol: Prediction of New Active Compounds Based on Sequence Motifs of Ligand Binding Sites in Proteins Using a Biochemical Language Model. Biomolecules 2023; 13:biom13050833. [PMID: 37238703 DOI: 10.3390/biom13050833] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2023] [Revised: 05/05/2023] [Accepted: 05/12/2023] [Indexed: 05/28/2023] Open
Abstract
In drug design, the prediction of new active compounds from protein sequence data has only been attempted in a few studies thus far. This prediction task is principally challenging because global protein sequence similarity has strong evolutional and structural implications, but is often only vaguely related to ligand binding. Deep language models adapted from natural language processing offer new opportunities to attempt such predictions via machine translation by directly relating amino acid sequences and chemical structures to each based on textual molecular representations. Herein, we introduce a biochemical language model with transformer architecture for the prediction of new active compounds from sequence motifs of ligand binding sites. In a proof-of-concept application on inhibitors of more than 200 human kinases, the Motif2Mol model revealed promising learning characteristics and an unprecedented ability to consistently reproduce known inhibitors of different kinases.
Collapse
Affiliation(s)
- Atsushi Yoshimori
- Institute for Theoretical Medicine, Inc., 26-1 Muraoka-Higashi 2-Chome, Fujisawa 251-0012, Japan
| | - Jürgen Bajorath
- Department of Life Science Informatics and Data Science, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Friedrich-Hirzebruch-Allee 5/6, 53115 Bonn, Germany
| |
Collapse
|
21
|
Chen H, Bajorath J. Designing highly potent compounds using a chemical language model. Sci Rep 2023; 13:7412. [PMID: 37150793 PMCID: PMC10164739 DOI: 10.1038/s41598-023-34683-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2023] [Accepted: 05/05/2023] [Indexed: 05/09/2023] Open
Abstract
Compound potency prediction is a major task in medicinal chemistry and drug design. Inspired by the concept of activity cliffs (which encode large differences in potency between similar active compounds), we have devised a new methodology for predicting potent compounds from weakly potent input molecules. Therefore, a chemical language model was implemented consisting of a conditional transformer architecture for compound design guided by observed potency differences. The model was evaluated using a newly generated compound test system enabling a rigorous assessment of its performance. It was shown to predict known potent compounds from different activity classes not encountered during training. Moreover, the model was capable of creating highly potent compounds that were structurally distinct from input molecules. It also produced many novel candidate compounds not included in test sets. Taken together, the findings confirmed the ability of the new methodology to generate structurally diverse highly potent compounds.
Collapse
Affiliation(s)
- Hengwei Chen
- Department of Life Science Informatics and Data Science, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Friedrich-Hirzebruch-Allee 5/6, 53115, Bonn, Germany
| | - Jürgen Bajorath
- Department of Life Science Informatics and Data Science, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Friedrich-Hirzebruch-Allee 5/6, 53115, Bonn, Germany.
| |
Collapse
|
22
|
Grisoni F. Chemical language models for de novo drug design: Challenges and opportunities. Curr Opin Struct Biol 2023; 79:102527. [PMID: 36738564 DOI: 10.1016/j.sbi.2023.102527] [Citation(s) in RCA: 12] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 12/07/2022] [Accepted: 12/20/2022] [Indexed: 02/05/2023]
Abstract
Generative deep learning is accelerating de novo drug design, by allowing the generation of molecules with desired properties on demand. Chemical language models - which generate new molecules in the form of strings using deep learning - have been particularly successful in this endeavour. Thanks to advances in natural language processing methods and interdisciplinary collaborations, chemical language models are expected to become increasingly relevant in drug discovery. This minireview provides an overview of the current state-of-the-art of chemical language models for de novo design, and analyses current limitations, challenges, and advantages. Finally, a perspective on future opportunities is provided.
Collapse
Affiliation(s)
- Francesca Grisoni
- Eindhoven University of Technology, Institute for Complex Molecular Systems and Dept. Biomedical Engineering, Eindhoven, Netherlands; Centre for Living Technologies, Alliance TU/e, WUR, UU, UMC Utrecht, Netherlands.
| |
Collapse
|
23
|
Seo S, Lim J, Kim WY. Molecular Generative Model via Retrosynthetically Prepared Chemical Building Block Assembly. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2023; 10:e2206674. [PMID: 36596675 PMCID: PMC10015872 DOI: 10.1002/advs.202206674] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Indexed: 06/17/2023]
Abstract
Deep generative models are attracting attention as a smart molecular design strategy. However, previous models often render molecules with low synthesizability, hindering their real-world applications. Here, a novel graph-based conditional generative model which makes molecules by tailoring retrosynthetically prepared chemical building blocks until achieving target properties in an auto-regressive fashion is proposed. This strategy improves the synthesizability and property control of the resulting molecules and also helps learn how to select appropriate building blocks and bind them together to achieve target properties. By applying a negative sampling method to the selection process of building blocks, this model overcame a critical limitation of previous fragment-based models, which can only use molecules from the training set during generation. As a result, the model works equally well with unseen building blocks without sacrificing computational efficiency. It is demonstrated that the model can generate potential inhibitors with high docking scores against the 3CL protease of SARS-COV-2.
Collapse
Affiliation(s)
- Seonghwan Seo
- HITS Incorporation124 Teheran‐ro, Gangnam‐guSeoul06234Republic of Korea
- Department of ChemistryKAIST, 291 Daehak‐ro, Yuseong‐guDaejeon34141Republic of Korea
| | - Jaechang Lim
- HITS Incorporation124 Teheran‐ro, Gangnam‐guSeoul06234Republic of Korea
| | - Woo Youn Kim
- HITS Incorporation124 Teheran‐ro, Gangnam‐guSeoul06234Republic of Korea
- Department of ChemistryKAIST, 291 Daehak‐ro, Yuseong‐guDaejeon34141Republic of Korea
- AI InstituteKAIST, 291 Daehak‐ro, Yuseong‐guDaejeon34141Republic of Korea
| |
Collapse
|
24
|
Bajorath J. Generative kinase inhibitor modeling viewed from a medicinal chemistry perspective. Future Med Chem 2023; 15:313-315. [PMID: 36892087 DOI: 10.4155/fmc-2023-0029] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/10/2023] Open
Affiliation(s)
- Jürgen Bajorath
- Department of Life Science Informatics & Data Science, B-IT, LIMES Program Unit Chemical Biology & Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Friedrich-Hirzebruch-Allee 5/6, D-53115, Bonn, Germany
| |
Collapse
|
25
|
Molecular Blueprinting by Word Processing. Symmetry (Basel) 2023. [DOI: 10.3390/sym15020357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
In this work, computer-assisted writing techniques for linear expressions of the structure of polycyclic molecules, branched molecules and clusters, based on formal languages, are tested. The techniques used only require the ability to process written texts, even just using a text editor, and one of the many available molecular drawing/optimization programs that accept input in the form of a SMILES string. A few specific syntactic operators acting on strings are characterized in terms of their effect on the corresponding structure, and although they are simply examples, they are already capable of producing non-trivial structures. The aim of this work is to encourage experiments that may lead to potentially interesting molecular schemata, in view of their symmetry and stereochemistry, as revealed by optimization, and to develop insight into the connection between formal expressions and structures. Given the simplicity and availability of the required tools, it can also be useful for education.
Collapse
|
26
|
Moret M, Pachon Angona I, Cotos L, Yan S, Atz K, Brunner C, Baumgartner M, Grisoni F, Schneider G. Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nat Commun 2023; 14:114. [PMID: 36611029 PMCID: PMC9825622 DOI: 10.1038/s41467-022-35692-6] [Citation(s) in RCA: 24] [Impact Index Per Article: 24.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2021] [Accepted: 12/19/2022] [Indexed: 01/09/2023] Open
Abstract
Generative chemical language models (CLMs) can be used for de novo molecular structure generation by learning from a textual representation of molecules. Here, we show that hybrid CLMs can additionally leverage the bioactivity information available for the training compounds. To computationally design ligands of phosphoinositide 3-kinase gamma (PI3Kγ), a collection of virtual molecules was created with a generative CLM. This virtual compound library was refined using a CLM-based classifier for bioactivity prediction. This second hybrid CLM was pretrained with patented molecular structures and fine-tuned with known PI3Kγ ligands. Several of the computer-generated molecular designs were commercially available, enabling fast prescreening and preliminary experimental validation. A new PI3Kγ ligand with sub-micromolar activity was identified, highlighting the method's scaffold-hopping potential. Chemical synthesis and biochemical testing of two of the top-ranked de novo designed molecules and their derivatives corroborated the model's ability to generate PI3Kγ ligands with medium to low nanomolar activity for hit-to-lead expansion. The most potent compounds led to pronounced inhibition of PI3K-dependent Akt phosphorylation in a medulloblastoma cell model, demonstrating efficacy of PI3Kγ ligands in PI3K/Akt pathway repression in human tumor cells. The results positively advocate hybrid CLMs for virtual compound screening and activity-focused molecular design.
Collapse
Affiliation(s)
- Michael Moret
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Irene Pachon Angona
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Leandro Cotos
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Shen Yan
- University of Zurich, University Children's Hospital, Children's Research Center, Pediatric Molecular Neuro-Oncology Research, Lengghalde 5, 8008, Zurich, Switzerland
| | - Kenneth Atz
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Cyrill Brunner
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland
| | - Martin Baumgartner
- University of Zurich, University Children's Hospital, Children's Research Center, Pediatric Molecular Neuro-Oncology Research, Lengghalde 5, 8008, Zurich, Switzerland
| | - Francesca Grisoni
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland. .,Eindhoven University of Technology, Institute for Complex Molecular Systems and Eindhoven Artificial Intelligence Systems Institute, Department of Biomedical Engineering, Groene Loper 7, 5612AZ, Eindhoven, The Netherlands. .,Center for 393 Living Technologies, Alliance TU/e, WUR, UU, UMC 394 Utrecht, Utrecht, 3584 CB, The Netherlands.
| | - Gisbert Schneider
- ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland. .,ETH Singapore SEC Ltd, 1 CREATE Way, #06-01 CREATE Tower, Singapore, 138602, Singapore.
| |
Collapse
|
27
|
Atz K, Guba W, Grether U, Schneider G. Machine Learning and Computational Chemistry for the Endocannabinoid System. Methods Mol Biol 2023; 2576:477-493. [PMID: 36152211 DOI: 10.1007/978-1-0716-2728-0_39] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Computational methods in medicinal chemistry facilitate drug discovery and design. In particular, machine learning methodologies have recently gained increasing attention. This chapter provides a structured overview of the current state of computational chemistry and its applications for the interrogation of the endocannabinoid system (ECS), highlighting methods in structure-based drug design, virtual screening, ligand-based quantitative structure-activity relationship (QSAR) modeling, and de novo molecular design. We emphasize emerging methods in machine learning and anticipate a forecast of future opportunities of computational medicinal chemistry for the ECS.
Collapse
Affiliation(s)
- Kenneth Atz
- ETH Zurich, Department of Chemistry and Applied Biosciences, Zurich, Switzerland
| | - Wolfgang Guba
- Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland
| | - Uwe Grether
- Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
| | - Gisbert Schneider
- ETH Zurich, Department of Chemistry and Applied Biosciences, Zurich, Switzerland
- ETH Singapore SEC Ltd, Singapore, Singapore
| |
Collapse
|
28
|
|
29
|
Li C, Wang C, Sun M, Zeng Y, Yuan Y, Gou Q, Wang G, Guo Y, Pu X. Correlated RNN Framework to Quickly Generate Molecules with Desired Properties for Energetic Materials in the Low Data Regime. J Chem Inf Model 2022; 62:4873-4887. [PMID: 35998331 DOI: 10.1021/acs.jcim.2c00997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Motivated by the challenging of deep learning on the low data regime and the urgent demand for intelligent design on highly energetic materials, we explore a correlated deep learning framework, which consists of three recurrent neural networks (RNNs) correlated by the transfer learning strategy, to efficiently generate new energetic molecules with a high detonation velocity in the case of very limited data available. To avoid the dependence on the external big data set, data augmentation by fragment shuffling of 303 energetic compounds is utilized to produce 500,000 molecules to pretrain RNN, through which the model can learn sufficient structure knowledge. Then the pretrained RNN is fine-tuned by focusing on the 303 energetic compounds to generate 7153 molecules similar to the energetic compounds. In order to more reliably screen the molecules with a high detonation velocity, the SMILE enumeration augmentation coupled with the pretrained knowledge is utilized to build an RNN-based prediction model, through which R2 is boosted from 0.4446 to 0.9572. The comparable performance with the transfer learning strategy based on an existing big database (ChEMBL) to produce the energetic molecules and drug-like ones further supports the effectiveness and generality of our strategy in the low data regime. High-precision quantum mechanics calculations further confirm that 35 new molecules present a higher detonation velocity and lower synthetic accessibility than the classic explosive RDX, along with good thermal stability. In particular, three new molecules are comparable to caged CL-20 in the detonation velocity. All the source codes and the data set are freely available at https://github.com/wangchenghuidream/RNNMGM.
Collapse
Affiliation(s)
- Chuan Li
- College of Computer Science, Sichuan University, Chengdu 610064, China
| | - Chenghui Wang
- College of Computer Science, Sichuan University, Chengdu 610064, China
| | - Ming Sun
- College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Yan Zeng
- College of Computer Science, Sichuan University, Chengdu 610064, China
| | - Yuan Yuan
- College of Management, Southwest University for Nationalities, Chengdu 610041, China
| | - Qiaolin Gou
- College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Guangchuan Wang
- College of Computer Science, Sichuan University, Chengdu 610064, China
| | - Yanzhi Guo
- College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Xuemei Pu
- College of Chemistry, Sichuan University, Chengdu 610064, China
| |
Collapse
|
30
|
Woodward DJ, Bradley AR, van Hoorn WP. Coverage Score: A Model Agnostic Method to Efficiently Explore Chemical Space. J Chem Inf Model 2022; 62:4391-4402. [PMID: 35867814 DOI: 10.1021/acs.jcim.2c00258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Selecting the most appropriate compounds to synthesize and test is a vital aspect of drug discovery. Methods like clustering and diversity present weaknesses in selecting the optimal sets for information gain. Active learning techniques often rely on an initial model and computationally expensive semi-supervised batch selection. Herein, we describe a new subset-based selection method, Coverage Score, that combines Bayesian statistics and information entropy to balance representation and diversity to select a maximally informative subset. Coverage Score can be influenced by prior selections and desirable properties. In this paper, subsets selected through Coverage Score are compared against subsets selected through model-independent and model-dependent techniques for several datasets. In drug-like chemical space, Coverage Score consistently selects subsets that lead to more accurate predictions compared to other selection methods. Subsets selected through Coverage Score produced Random Forest models that have a root-mean-square-error up to 12.8% lower than subsets selected at random and can retain up to 99% of the structural dissimilarity of a diversity selection.
Collapse
Affiliation(s)
- Daniel J Woodward
- Exscientia plc, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, U.K
| | - Anthony R Bradley
- Exscientia plc, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, U.K
| | - Willem P van Hoorn
- Exscientia plc, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, U.K
| |
Collapse
|
31
|
Blay V, Radivojevic T, Allen JE, Hudson CM, Garcia Martin H. MACAW: An Accessible Tool for Molecular Embedding and Inverse Molecular Design. J Chem Inf Model 2022; 62:3551-3564. [PMID: 35857932 PMCID: PMC9364320 DOI: 10.1021/acs.jcim.2c00229] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
![]()
The growing capabilities of synthetic biology and organic
chemistry
demand tools to guide syntheses toward useful molecules. Here, we
present Molecular AutoenCoding Auto-Workaround (MACAW), a tool that
uses a novel approach to generate molecules predicted to meet a desired
property specification (e.g., a binding affinity of 50 nM or an octane
number of 90). MACAW describes molecules by embedding them into a
smooth multidimensional numerical space, avoiding uninformative dimensions
that previous methods often introduce. The coordinates in this embedding
provide a natural choice of features for accurately predicting molecular
properties, which we demonstrate with examples for cetane and octane
numbers, flash points, and histamine H1 receptor binding affinity.
The approach is computationally efficient and well-suited to the small-
and medium-size datasets commonly used in biosciences. We showcase
the utility of MACAW for virtual screening by identifying molecules
with high predicted binding affinity to the histamine H1 receptor
and limited affinity to the muscarinic M2 receptor, which are targets
of medicinal relevance. Combining these predictive capabilities with
a novel generative algorithm for molecules allows us to recommend
molecules with a desired property value (i.e., inverse molecular design).
We demonstrate this capability by recommending molecules with predicted
octane numbers of 40, 80, and 120, which is an important characteristic
of biofuels. Thus, MACAW augments classical retrosynthesis tools by
providing recommendations for molecules on specification.
Collapse
Affiliation(s)
- Vincent Blay
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.,Biofuels and Bioproducts Division, DOE Joint BioEnergy Institute, Emeryville, California 94608, United States
| | - Tijana Radivojevic
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.,Biofuels and Bioproducts Division, DOE Joint BioEnergy Institute, Emeryville, California 94608, United States.,DOE Agile BioFoundry, Emeryville, California 94608, United States
| | - Jonathan E Allen
- Global Security Computing Applications, Lawrence Livermore National Laboratory, Livermore, California 94550, United States
| | - Corey M Hudson
- Sandia National Laboratories, Livermore, California 94550, United States
| | - Hector Garcia Martin
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.,Biofuels and Bioproducts Division, DOE Joint BioEnergy Institute, Emeryville, California 94608, United States.,DOE Agile BioFoundry, Emeryville, California 94608, United States
| |
Collapse
|
32
|
Yoshimori A, Bajorath J. DeepAS - Chemical language model for the extension of active analogue series. Bioorg Med Chem 2022; 66:116808. [PMID: 35567984 DOI: 10.1016/j.bmc.2022.116808] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2022] [Revised: 04/28/2022] [Accepted: 05/04/2022] [Indexed: 11/30/2022]
Abstract
In medicinal chemistry, hit-to-lead and lead optimization efforts produce analogue series (ASs), the analysis of which is of central relevance for the exploration and exploitation of structure-activity relationships (SARs) and generation of candidate compounds. The key question in any chemical optimization effort is which analogue(s) to generate next, for which computational support is typically provided through QSAR analysis and compound potency predictions. In this study, we introduce a new chemical language model for analogue design via deep learning. For this purpose, ASs comprising active compounds are ordered according to increasing potency and the chemical language model predicts preferred R-groups for new analogues on the basis of ordered R-group sequences. Hence, consistent with the principles of deep models for natural language processing, analogues with new R-groups are predicted based upon conditional probabilities taking preceding groups into account. This implicitly accounts for the potency gradient captured by an AS and detectable SAR trends, providing a new concept for analogue design. Herein, we report the AS-based chemical language model, its initial evaluation, and exemplary applications.
Collapse
Affiliation(s)
- Atsushi Yoshimori
- Institute for Theoretical Medicine, Inc., 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-0012, Japan
| | - Jürgen Bajorath
- Department of Life Science Informatics and Data Science, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Friedrich-Hirzebruch-Allee 5/6, D-53115 Bonn, Germany.
| |
Collapse
|
33
|
Yoshimori A, Bajorath J. Computational analysis, alignment and extension of analogue series from medicinal chemistry. Future Sci OA 2022; 8:FSO804. [PMID: 36248066 PMCID: PMC9540237 DOI: 10.2144/fsoa-2022-0033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Accepted: 06/10/2022] [Indexed: 11/23/2022] Open
Affiliation(s)
- Atsushi Yoshimori
- Department of Life Science Informatics & Data Science, B-IT, LIMES Program Unit Chemical Biology & Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Friedrich-Hirzebruch-Allee 5/6, Bonn, D 53115, Germany
| | - Jürgen Bajorath
- Institute for Theoretical Medicine, Inc., 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 2510012, Japan
| |
Collapse
|
34
|
Singh S, Sunoj RB. A Transfer Learning Approach for Reaction Discovery in Small Data Situations Using Generative Model. iScience 2022; 25:104661. [PMID: 35832891 PMCID: PMC9272387 DOI: 10.1016/j.isci.2022.104661] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2022] [Revised: 05/20/2022] [Accepted: 06/16/2022] [Indexed: 11/01/2022] Open
Abstract
Sustainable practices in chemical sciences can be better realized by adopting interdisciplinary approaches that combine the advantages of machine learning (ML) on the initially acquired small data in reaction discovery. Developing new reactions generally remains heuristic and even time and resource intensive. For instance, synthesis of fluorine-containing compounds, which constitute ∼20% of the marketed drugs, relies on deoxyfluorination of abundantly available alcohols. Herein, we demonstrate the use of a recurrent neural network-based deep generative model built on a library of just 37 alcohols for effective learning and exploration of the chemical space. The proof-of-concept ML model is able to generate good quality, synthetically accessible, higher-yielding novel alcohol molecules. This protocol would have superior utility for deployment into a practical reaction discovery pipeline. Dual pronged transfer learning, both to generate and predict yields of new molecules Demonstrated the utility for an important family of deoxyfluorination of alcohols Applicable for practically more likely situations with relatively smaller data Extendable to other reaction manifolds to facilitate expedited reaction discovery
Collapse
|
35
|
Moret M, Grisoni F, Katzberger P, Schneider G. Perplexity-Based Molecule Ranking and Bias Estimation of Chemical Language Models. J Chem Inf Model 2022; 62:1199-1206. [PMID: 35191696 PMCID: PMC8924923 DOI: 10.1021/acs.jcim.2c00079] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Chemical language models (CLMs) can be employed to design molecules with desired properties. CLMs generate new chemical structures in the form of textual representations, such as the simplified molecular input line entry system (SMILES) strings. However, the quality of these de novo generated molecules is difficult to assess a priori. In this study, we apply the perplexity metric to determine the degree to which the molecules generated by a CLM match the desired design objectives. This model-intrinsic score allows identifying and ranking the most promising molecular designs based on the probabilities learned by the CLM. Using perplexity to compare "greedy" (beam search) with "explorative" (multinomial sampling) methods for SMILES generation, certain advantages of multinomial sampling become apparent. Additionally, perplexity scoring is performed to identify undesired model biases introduced during model training and allows the development of a new ranking system to remove those undesired biases.
Collapse
Affiliation(s)
- Michael Moret
- Department of Chemistry and Applied Biosciences, ETH Zurich, RETHINK, Vladimir-Prelog-Weg 4, Zurich 8093, Switzerland
| | - Francesca Grisoni
- Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Groene Loper 7, Eindhoven 5612AZ, Netherlands.,Center for Living Technologies, Alliance TU/e, WUR, UU, UMC Utrecht, Princetonlaan 6, Utrecht 3584 CB, The Netherlands
| | - Paul Katzberger
- Department of Chemistry and Applied Biosciences, ETH Zurich, RETHINK, Vladimir-Prelog-Weg 4, Zurich 8093, Switzerland
| | - Gisbert Schneider
- Department of Chemistry and Applied Biosciences, ETH Zurich, RETHINK, Vladimir-Prelog-Weg 4, Zurich 8093, Switzerland.,ETH Singapore SEC Ltd., 1 CREATE Way, #06-01 CREATE Tower, Singapore 138602, Singapore
| |
Collapse
|
36
|
|
37
|
A deep generative model enables automated structure elucidation of novel psychoactive substances. NAT MACH INTELL 2021. [DOI: 10.1038/s42256-021-00407-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
38
|
High-confidence structural annotation of metabolites absent from spectral libraries. Nat Biotechnol 2021; 40:411-421. [PMID: 34650271 PMCID: PMC8926923 DOI: 10.1038/s41587-021-01045-9] [Citation(s) in RCA: 89] [Impact Index Per Article: 29.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Accepted: 08/04/2021] [Indexed: 12/14/2022]
Abstract
Untargeted metabolomics experiments rely on spectral libraries for structure annotation, but, typically, only a small fraction of spectra can be matched. Previous in silico methods search in structure databases but cannot distinguish between correct and incorrect annotations. Here we introduce the COSMIC workflow that combines in silico structure database generation and annotation with a confidence score consisting of kernel density P value estimation and a support vector machine with enforced directionality of features. On diverse datasets, COSMIC annotates a substantial number of hits at low false discovery rates and outperforms spectral library search. To demonstrate that COSMIC can annotate structures never reported before, we annotated 12 natural bile acids. The annotation of nine structures was confirmed by manual evaluation and two structures using synthetic standards. In human samples, we annotated and manually validated 315 molecular structures currently absent from the Human Metabolome Database. Application of COSMIC to data from 17,400 metabolomics experiments led to 1,715 high-confidence structural annotations that were absent from spectral libraries.
Collapse
|
39
|
Chen JM, Zovko M, Šimurina N, Zovko V. Fear in a Handful of Dust: The Epidemiological, Environmental, and Economic Drivers of Death by PM 2.5 Pollution. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:8688. [PMID: 34444435 PMCID: PMC8393768 DOI: 10.3390/ijerph18168688] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Revised: 08/03/2021] [Accepted: 08/14/2021] [Indexed: 01/13/2023]
Abstract
This study evaluates numerous epidemiological, environmental, and economic factors affecting morbidity and mortality from PM2.5 exposure in the 27 member states of the European Union. This form of air pollution inflicts considerable social and economic damage in addition to loss of life and well-being. This study creates and deploys a comprehensive data pipeline. The first step consists of conventional linear models and supervised machine learning alternatives. Those regression methods do more than predict health outcomes in the EU-27 and relate those predictions to independent variables. Linear regression and its machine learning equivalents also inform unsupervised machine learning methods such as clustering and manifold learning. Lower-dimension manifolds of this dataset's feature space reveal the relationship among EU-27 countries and their success (or failure) in managing PM2.5 morbidity and mortality. Principal component analysis informs further interpretation of variables along economic and health-based lines. A nonlinear environmental Kuznets curve may describe the fuller relationship between economic activity and premature death from PM2.5 exposure. The European Union should bridge the historical, cultural, and economic gaps that impair these countries' collective response to PM2.5 pollution.
Collapse
Affiliation(s)
- James Ming Chen
- College of Law, Michigan State University, East Lansing, MI 48824, USA
| | - Mira Zovko
- Ministry of Economy and Sustainable Development, 10000 Zagreb, Croatia;
| | - Nika Šimurina
- Faculty of Economics & Business, University of Zagreb, 10000 Zagreb, Croatia;
| | - Vatroslav Zovko
- Faculty of Teacher Education, University of Zagreb, 10000 Zagreb, Croatia;
| |
Collapse
|